GLP-1 drugs were initially developed for type 2 diabetes but are now widely used to treat obesity. Novo Nordisk and Eli Lilly lead in GLP-1 drug production, with others like Viking Therapeutics ...

Kevin George is a crypto writer and editor for Investopedia. He holds a master's degree in finance and has extensive knowledge and experience in the areas of trading, markets, and economics. Dr.

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. It’s no secret that we love Amazon. New here?